Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature

Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is...

Full description

Saved in:
Bibliographic Details
Published inTremor and other hyperkinetic movements (New York, N.Y.) Vol. 7; p. 454
Main Authors Tarolli, Christopher G, Chesire, Amy M, Biglan, Kevin M
Format Journal Article
LanguageEnglish
Published United States Columbia University Libraries/Information Services 01.01.2017
Ubiquity Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease. In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care. We provide a review of the current literature and discuss our own care practices. We conclude by discussing questions that remain unanswered and positing ideas for future work in the field.
AbstractList Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.BACKGROUNDHuntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.METHODSIn this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.We provide a review of the current literature and discuss our own care practices.RESULTSWe provide a review of the current literature and discuss our own care practices.We conclude by discussing questions that remain unanswered and positing ideas for future work in the field.DISCUSSIONWe conclude by discussing questions that remain unanswered and positing ideas for future work in the field.
Background Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.Methods In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.Results We provide a review of the current literature and discuss our own care practices.Discussion We conclude by discussing questions that remain unanswered and positing ideas for future work in the field.
Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease. In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care. We provide a review of the current literature and discuss our own care practices. We conclude by discussing questions that remain unanswered and positing ideas for future work in the field.
Author Chesire, Amy M
Tarolli, Christopher G
Biglan, Kevin M
AuthorAffiliation 2 Early Phase Clinical Development, Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
Yale University, USA
1 Department of Neurology, University of Rochester, Rochester, NY, USA
AuthorAffiliation_xml – name: Yale University, USA
– name: 1 Department of Neurology, University of Rochester, Rochester, NY, USA
– name: 2 Early Phase Clinical Development, Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
Author_xml – sequence: 1
  givenname: Christopher G
  surname: Tarolli
  fullname: Tarolli, Christopher G
  organization: Department of Neurology, University of Rochester, Rochester, NY, USA
– sequence: 2
  givenname: Amy M
  surname: Chesire
  fullname: Chesire, Amy M
  organization: Department of Neurology, University of Rochester, Rochester, NY, USA
– sequence: 3
  givenname: Kevin M
  surname: Biglan
  fullname: Biglan, Kevin M
  organization: Early Phase Clinical Development, Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28428907$$D View this record in MEDLINE/PubMed
BookMark eNpVkUtvFDEQhC0URB5E4hcgH7ks-DEztjkgoU1IIq1EhODCxWrbPRtHs3awPYv49wwkoKQvXapufXWoY3KQckJCXnH2Vhk-vDvTmvVqrZ6RI8EHttJC64NH-pCc1nrLlumVEV3_ghwK3QltmDoi369hmiK0uEe6hoI0Jno5pxbTtuVEz2JFqPieXmOpOcFEv-A4oW8xp0ohBQqLs4_4k-aRthukm9iwQJsLviTPR5gqnj7sE_Lt0_nX9eVq8_niav1xswpSirbqtYDBCKWY8ZyPGlTwoxoX7bpRM-aEkn7wIqjeMIkDgJOMB82cdgGckyfk6p4bMtzauxJ3UH7ZDNH-NXLZWigt-gmtY2jcyEEI7zsHwfUmOOTeGOmE9mZhfbhn3c1uh8FjagWmJ9CnlxRv7DbvbS9NP6g_gDcPgJJ_zFib3cXqcZogYZ6r5dpw3jFtuuX19eOs_yH_ypG_AYo3k_8
ContentType Journal Article
Copyright 2017 Tarolli et al. 2017 Tarolli et al.
Copyright_xml – notice: 2017 Tarolli et al. 2017 Tarolli et al.
DBID NPM
7X8
5PM
DOA
DOI 10.7916/D88057C7
DatabaseName PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Palliative Care in Huntington Disease
EISSN 2160-8288
ExternalDocumentID oai_doaj_org_article_b0e9bf1a22cc4badb59dbe1c993b28c9
PMC5395679
28428907
Genre Journal Article
Review
GroupedDBID .0O
53G
5VS
7X7
8FI
8FJ
AAFWJ
ABUWG
ADBBV
ADRAZ
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
CCPQU
DIK
DWQXO
EMOBN
FRJ
FYUFA
GNUQQ
GROUPED_DOAJ
H13
HMCUK
HYE
KQ8
M2M
M48
M~E
NPM
OK1
PGMZT
PIMPY
PSYQQ
RPM
UKHRP
7X8
PHGZM
PHGZT
5PM
PUEGO
ID FETCH-LOGICAL-d332t-582a6927709c11f8a7dcf7fc11b4f800b273c6c2d75903e6aab301d80b8bdabb3
IEDL.DBID M48
ISSN 2160-8288
IngestDate Wed Aug 27 01:31:30 EDT 2025
Thu Aug 21 18:26:20 EDT 2025
Thu Jul 10 22:24:45 EDT 2025
Thu Jan 02 22:25:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords hospice
advance care planning
palliative care
caregiver burden
Huntington disease
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommerical–No Derivatives License, which permits the user to copy, distribute, and transmit the work provided that the original author and source are credited; that no commercial use is made of the work; and that the work is not altered or transformed.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d332t-582a6927709c11f8a7dcf7fc11b4f800b273c6c2d75903e6aab301d80b8bdabb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.7916/D88057C7
PMID 28428907
PQID 1891140894
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_b0e9bf1a22cc4badb59dbe1c993b28c9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5395679
proquest_miscellaneous_1891140894
pubmed_primary_28428907
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Tremor and other hyperkinetic movements (New York, N.Y.)
PublicationTitleAlternate Tremor Other Hyperkinet Mov (N Y)
PublicationYear 2017
Publisher Columbia University Libraries/Information Services
Ubiquity Press
Publisher_xml – name: Columbia University Libraries/Information Services
– name: Ubiquity Press
References 24195904 - Am J Occup Ther. 2013 Nov-Dec;67(6):704-10
15008126 - J Palliat Med. 2004 Feb;7(1):19-25
25411649 - Tremor Other Hyperkinet Mov (N Y). 2014 Nov 12;4:257
19415556 - Health Commun. 2009 Apr;24(3):239-48
22867994 - Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S6-9
8108531 - Psychol Med. 1993;Suppl 23:1-46
25728958 - Lancet Neurol. 2015 Apr;14(4):435-42
25330167 - JAMA Intern Med. 2014 Dec;174(12):1994-2003
19639395 - J Clin Psychol Med Settings. 2009 Dec;16(4):355-62
26447070 - JBI Database System Rev Implement Rep. 2015 May 15;13(4):14-29
26150131 - Cancer. 2015 Oct 15;121(20):3737-45
24618967 - JAMA. 2014 Mar 12;311(10):1052-60
154626 - Neurology. 1979 Jan;29(1):1-3
16467346 - BMJ. 2006 Mar 4;332(7540):515-21
22477667 - J Cancer Educ. 2012 Jun;27(3):515-20
24052430 - Am J Hosp Palliat Care. 2015 Feb;32(1):68-77
23698451 - Palliat Med. 2013 Dec;27(10):918-24
19276225 - Chronic Illn. 2009 Mar;5(1):46-55
24991027 - Neurology. 2014 Aug 5;83(6):561-7
25806882 - Oncol Nurs Forum. 2015 Mar;42(2):156-64
26918202 - Neurol Clin Pract. 2016 Feb;6(1):40-48
8866495 - Mov Disord. 1996 Sep;11(5):542-8
11176966 - Arch Neurol. 2001 Feb;58(2):273-8
8657216 - N Engl J Med. 1996 Jul 18;335(3):172-8
27938026 - J Soc Work End Life Palliat Care. 2016 Oct-Dec;12 (4):348-365
20423385 - J Adv Nurs. 2010 Mar;66(3):500-10
8291568 - Am J Med Genet. 1993 Oct 15;48(3):145-50
20818875 - N Engl J Med. 2010 Aug 19;363(8):733-42
22692795 - Mov Disord. 2012 Aug;27(9):1083-91
20078215 - J Palliat Med. 2010 Mar;13(3):267-71
24964036 - PLoS One. 2014 Jun 25;9(6):e100435
18070848 - J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):441-8
18581443 - Mov Disord. 2008 Aug 15;23(11):1491-504
18619087 - Care Manag J. 2008;9(2):75-81
23876040 - J Palliat Med. 2013 Aug;16(8):818-9
26688844 - Psychiatr Pol. 2015 ;49(5):931-44
23175514 - Palliat Med. 2013 May;27(5):389-400
22761268 - Cleve Clin J Med. 2012 Jul;79 Suppl 2:S30-4
7806741 - J Am Geriatr Soc. 1995 Jan;43(1):56-9
9532400 - Camb Q Healthc Ethics. 1998 Spring;7(2):206-7
18175350 - Mov Disord. 2008 Apr 15;23(5):721-6
9288011 - J Am Geriatr Soc. 1997 Sep;45(9):1054-9
21538527 - Mov Disord. 2011 Aug 1;26(9):1711-6
24126537 - JAMA Neurol. 2013 Dec;70(12 ):1520-30
10605972 - JAMA. 1999 Dec 15;282(23):2215-9
16387989 - J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):496-502
24152480 - Br J Gen Pract. 2013 Oct;63(615):e657-68
21707857 - Psychogeriatrics. 2011 Jun;11(2):98-104
17491500 - Clin Med (Lond). 2007 Apr;7(2):129-36
References_xml – reference: 11176966 - Arch Neurol. 2001 Feb;58(2):273-8
– reference: 18619087 - Care Manag J. 2008;9(2):75-81
– reference: 22761268 - Cleve Clin J Med. 2012 Jul;79 Suppl 2:S30-4
– reference: 16467346 - BMJ. 2006 Mar 4;332(7540):515-21
– reference: 22692795 - Mov Disord. 2012 Aug;27(9):1083-91
– reference: 21707857 - Psychogeriatrics. 2011 Jun;11(2):98-104
– reference: 25411649 - Tremor Other Hyperkinet Mov (N Y). 2014 Nov 12;4:257
– reference: 22867994 - Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S6-9
– reference: 17491500 - Clin Med (Lond). 2007 Apr;7(2):129-36
– reference: 8108531 - Psychol Med. 1993;Suppl 23:1-46
– reference: 25330167 - JAMA Intern Med. 2014 Dec;174(12):1994-2003
– reference: 20078215 - J Palliat Med. 2010 Mar;13(3):267-71
– reference: 19415556 - Health Commun. 2009 Apr;24(3):239-48
– reference: 24991027 - Neurology. 2014 Aug 5;83(6):561-7
– reference: 27938026 - J Soc Work End Life Palliat Care. 2016 Oct-Dec;12 (4):348-365
– reference: 9532400 - Camb Q Healthc Ethics. 1998 Spring;7(2):206-7
– reference: 20423385 - J Adv Nurs. 2010 Mar;66(3):500-10
– reference: 26918202 - Neurol Clin Pract. 2016 Feb;6(1):40-48
– reference: 26150131 - Cancer. 2015 Oct 15;121(20):3737-45
– reference: 24195904 - Am J Occup Ther. 2013 Nov-Dec;67(6):704-10
– reference: 23698451 - Palliat Med. 2013 Dec;27(10):918-24
– reference: 16387989 - J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):496-502
– reference: 18070848 - J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):441-8
– reference: 24052430 - Am J Hosp Palliat Care. 2015 Feb;32(1):68-77
– reference: 25728958 - Lancet Neurol. 2015 Apr;14(4):435-42
– reference: 25806882 - Oncol Nurs Forum. 2015 Mar;42(2):156-64
– reference: 19276225 - Chronic Illn. 2009 Mar;5(1):46-55
– reference: 24126537 - JAMA Neurol. 2013 Dec;70(12 ):1520-30
– reference: 22477667 - J Cancer Educ. 2012 Jun;27(3):515-20
– reference: 8291568 - Am J Med Genet. 1993 Oct 15;48(3):145-50
– reference: 24152480 - Br J Gen Pract. 2013 Oct;63(615):e657-68
– reference: 18581443 - Mov Disord. 2008 Aug 15;23(11):1491-504
– reference: 26688844 - Psychiatr Pol. 2015 ;49(5):931-44
– reference: 10605972 - JAMA. 1999 Dec 15;282(23):2215-9
– reference: 154626 - Neurology. 1979 Jan;29(1):1-3
– reference: 15008126 - J Palliat Med. 2004 Feb;7(1):19-25
– reference: 24964036 - PLoS One. 2014 Jun 25;9(6):e100435
– reference: 8657216 - N Engl J Med. 1996 Jul 18;335(3):172-8
– reference: 21538527 - Mov Disord. 2011 Aug 1;26(9):1711-6
– reference: 19639395 - J Clin Psychol Med Settings. 2009 Dec;16(4):355-62
– reference: 8866495 - Mov Disord. 1996 Sep;11(5):542-8
– reference: 26447070 - JBI Database System Rev Implement Rep. 2015 May 15;13(4):14-29
– reference: 24618967 - JAMA. 2014 Mar 12;311(10):1052-60
– reference: 23876040 - J Palliat Med. 2013 Aug;16(8):818-9
– reference: 7806741 - J Am Geriatr Soc. 1995 Jan;43(1):56-9
– reference: 18175350 - Mov Disord. 2008 Apr 15;23(5):721-6
– reference: 9288011 - J Am Geriatr Soc. 1997 Sep;45(9):1054-9
– reference: 23175514 - Palliat Med. 2013 May;27(5):389-400
– reference: 20818875 - N Engl J Med. 2010 Aug 19;363(8):733-42
SSID ssj0000579245
Score 2.1007407
SecondaryResourceType review_article
Snippet Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and...
Background Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances,...
SourceID doaj
pubmedcentral
proquest
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 454
SubjectTerms Reviews
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journal (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yB_Eivl1fRPBats2jabz5ZBGVRRQWLyWTBwrSFV3_v5Omyq4IXoSe2kOHmUnmm5nkG0KOhPdSBVtkKjCZCfSYDGTJM_CiyB1X3oRY77i5LYcP4mosxzOjvuKZsEQPnBQ3gNxrCIVhzFoBxoHUDnxhMa4Cq2x7dQ9j3kwylVi9FSYWMrHNKoRAg3N0VKnOVMfN_xug_HkucibQXK6Q5Q4h0pMk2SpZ8M0aWbzpeuDr5HFkYokkblM03h6izw0dpoEPiOPoeeq4HNNRB7PpnQ8v7YGr5p2axlFDU0OATgJF-Eevv5mVN8jD5cX92TDrJiRkjnM2zWTFTKmZUrm2RREqo5wNUfUFiIBQEBCc2NIyp6TOuS-NAVzQrsqhAmcA-CbpNZPGbxOa86DwcSxoLjzuPQh1vJDM5NyA1VWfnEa91a-JBKOOtNTtCzRW3Rmr_stYfXL4pfUa3Tj2JkzjJx_vdVHhrivySos-2UpW-P4VRtDYDlV9oubsMyfL_Jfm-amlypYc8z-ld_5D-F2yxGJMb-sve6Q3ffvw-4hIpnDQOt8nEXvjjg
  priority: 102
  providerName: Directory of Open Access Journals
Title Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature
URI https://www.ncbi.nlm.nih.gov/pubmed/28428907
https://www.proquest.com/docview/1891140894
https://pubmed.ncbi.nlm.nih.gov/PMC5395679
https://doaj.org/article/b0e9bf1a22cc4badb59dbe1c993b28c9
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3La9tAEIeHPKD0UtK3k9ZsoVel0j402l5K88KUOphQg-lF7DMNBLmxHWj_-85KcqhDTgGdJBaJndndb3ZWvwH4KENQGF2RYeQqk-QxmVWlyGyQRe4FBhPTfsf4vBxN5beZmm3Butpm34HLB0O7VE9qurg-_HPz9wsNeOLXQyS6-XRCPqjwGLdhl9YjTHUMxj3kdwrfSEGG6pRnNxokJeBKplQb9pL9D3Hm_eOS_60_Z3vwrAdH9rWz9HPYCs0LeDLuU-Mv4efEpJ2TNHux9FMRu2rYqKsDQXjHTrpEzGc26embXYR43Z7DapbMNJ4Z1uUJ2DwyokL2_U5w-RVMz05_HI-yvnBC5oXgq0xV3JSaI-baFUWsDHoXk0UKKyMRoiVmcaXjHpXORSiNsTTOfZXbynpjrXgNO828CW-B5SIiXZ5HLWSgKYkIKEjFTS6MdboawFHqt_p3p41RJ7Xq9sZ8cVn3zl_bPGgbC8O5c9Iab5X2NhSO2MjyyukBfFj3ek3enVIWpgnz22VdVDQZy7zScgBvOivcvWptugHghn02vmXzSXP1q1XQVoLCQtT7j255AE95Wt_bvZh3sLNa3Ib3RCcrO4RtnOEQdo9OzycXwzbGH7YO-Q-PZesr
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Palliative+Care+in+Huntington+Disease%3A+Personal+Reflections+and+a+Review+of+the+Literature&rft.jtitle=Tremor+and+other+hyperkinetic+movements+%28New+York%2C+N.Y.%29&rft.au=Tarolli%2C+Christopher+G.&rft.au=Chesire%2C+Amy+M.&rft.au=Biglan%2C+Kevin+M.&rft.date=2017-01-01&rft.pub=Columbia+University+Libraries%2FInformation+Services&rft.eissn=2160-8288&rft.volume=7&rft_id=info:doi/10.7916%2FD88057C7&rft_id=info%3Apmid%2F28428907&rft.externalDocID=PMC5395679
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2160-8288&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2160-8288&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2160-8288&client=summon